Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

2(33.3%)

Phase 1

2(33.3%)

N/A

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 2(2)

Phase 1(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06258525Phase 2Not Yet Recruiting

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Role: collaborator

NCT04520139Phase 1Not Yet Recruiting

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Role: collaborator

NCT02811133Phase 1Withdrawn

Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder

Role: collaborator

NCT00857376Phase 2Completed

Dose Ranging Study of the Effects of Alpha Lipoic Acid on Oxidative Stress

Role: collaborator

NCT00641199Not ApplicableCompleted

Probiotics for Prevention of Antibiotic-associated Diarrhea

Role: collaborator

NCT00300937Phase 3Completed

Coenzyme Q10 Supplementation and Development of Preeclampsia

Role: collaborator

All 6 trials loaded